Refloralization™

About ProgenaBiome

Founded in 2017, ProgenaBiome is a private, physician-owned genetic research lab that bridges microbiome science and clinical application. Its core business involves providing microbiome testing services (the Flora Test) to physicians and patients while actively conducting research into the role of the gut microbiome in various diseases, including Parkinson's. The company's strategy centers on validating sequencing data for clinical use, developing its refloralization (FMT) protocols, and seeking collaborations with doctors, scientists, and pharmaceutical companies. It appears to be in an early-revenue stage, generating income from testing services while funding research initiatives.

Therapeutic Areas